rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
34
|
pubmed:dateCreated |
2009-11-26
|
pubmed:abstractText |
Treatment options for metastatic melanoma are limited. We conducted this phase II trial to assess the efficacy of JS1/34.5-/47-/granulocyte-macrophage colony-stimulating factor (GM-CSF) in stages IIIc and IV disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:AmatrudaThomasT,
pubmed-author:CoffinRobertR,
pubmed-author:DanielsGregoryG,
pubmed-author:GlaspyJohnJ,
pubmed-author:GoldsweigHowardH,
pubmed-author:GonzalezReneR,
pubmed-author:HarringtonKevinK,
pubmed-author:KaufmanHoward LHL,
pubmed-author:LoveColinC,
pubmed-author:MarshallTraceyT,
pubmed-author:NemunaitisJohn JJJ,
pubmed-author:NemunaitisMikeM,
pubmed-author:SenzerNeil NNN,
pubmed-author:WhitmanEricE,
pubmed-author:WuJ LJL
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5763-71
|
pubmed:meshHeading |
pubmed-meshheading:19884534-Adult,
pubmed-meshheading:19884534-Aged,
pubmed-meshheading:19884534-Aged, 80 and over,
pubmed-meshheading:19884534-Female,
pubmed-meshheading:19884534-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:19884534-Herpesvirus 1, Human,
pubmed-meshheading:19884534-Humans,
pubmed-meshheading:19884534-Injections, Intralesional,
pubmed-meshheading:19884534-Male,
pubmed-meshheading:19884534-Melanoma,
pubmed-meshheading:19884534-Middle Aged,
pubmed-meshheading:19884534-Oncolytic Virotherapy,
pubmed-meshheading:19884534-Skin Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.
|
pubmed:affiliation |
Mary Crowley Cancer Research Centers, Dallas, TX 75201, USA. nsenzer@marycrowley.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|